Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R. 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Fairness in Orphan Drug Exclusivity Act
Client: AQUESTIVE THERAPEUTICS, INC · Firm: RUBICON ADVISORS, LLC
H.R. 1629/S 250: Fairness in Orphan Drug Exclusivity Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Rare disease issues Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Source: Senate LDA
| OFFICE OF GOVERNOR NATHAN DEAL |
| 24 |
| 2011–2016 |
| CONSCIOUS DISCIPLINE | 21 | 2017–2021 |
| COLLEGE OF AMERICAN PATHOLOGISTS | 19 | 2013–2017 |
| ALLIANCE TO PREVENT THE ABUSE OF MEDICINES | 18 | 2013–2017 |
| INSMED INCORPORATED | 17 | 2007–2011 |
| STATE MUTUAL INSURANCE COMPANY | 15 | 2013–2018 |
| LANNETT COMPANY, INC. | 14 | 2018–2021 |
| OSMOTICA PHARMACEUTICALS | 14 | 2008–2011 |
| AVET PHARMACEUTICALS | 12 | 2019–2021 |
| AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS | 11 | 2007–2009 |
| ALBANY MOLECULAR RESEARCH INC. | 9 | 2016–2018 |
| HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH AND CO KG | 9 | 2007–2008 |
| ASCENDIS PHARMA, INC. | 8 | 2020–2021 |
| CHILDREN'S HOSPITAL AND RESEARCH CENTER | 8 | 2010–2011 |
| FLEMING PHARMACEUTICALS | 7 | 2007–2008 |
| RANBAXY PHARMACEUTICALS INC | 7 | 2007–2008 |
| CIPLA USA INC | 6 | 2015–2016 |
| HYPOPARATHYROIDISM ASSOCIATION | 6 | 2020–2021 |
| BIOPURE CORPORATION | 3 | 2007 |
| PURE BLUE DIAGNOSTICS, A DIVISION OF PURE BLUE MEDICAL | 3 | 2020 |
| BIOMARIN PHARMACEUTICAL INC. | 2 | 2007 |
| GLASER PEDIATRIC AIDS FOUNDATION ELIZABETH | 2 | 2007 |
| Aquestive Therapeutics, Inc. | 1 | 2021 |
| MONUMENT GROUP LLC | 1 | 2007 |
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
Pharmaceuticals HR 707, Restoration of America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Restoration of America's Wire Act
Client: OFFICE OF GOVERNOR NATHAN DEAL · Firm: RUBICON ADVISORS, LLC
HR 707, Restoring America's Wire Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Air Traffic Control Tower Funding Restoration Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Air Traffic Control Tower Funding Restoration Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Justice Safety Valve Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Federal Reserve Independence Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
District of Columbia Government Shutdown Avoidance Act of 2013
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Strengthening Domestic Nuclear Security Act of 2014
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Behavioral Health Information Technology Coordination Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
All Year School Study Act
Client: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Firm: RUBICON ADVISORS, LLC
Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Postal Service Protection Act of 2013
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Creating Sunshine, Participation, and Accountability for our Nation Act
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Broadband Conduit Deployment Act of 2011
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Broadband Conduit Deployment Act of 2011
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Broadband Conduit Deployment Act of 2011
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Broadband Conduit Deployment Act of 2011
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: WATSON PHARMACEUTICALS INC · Firm: RUBICON ADVISORS, LLC
Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029
To specify the priority of the obligations of the United States Government if the debt ceiling is reached, to provide for an emergency appropriation of funds to pay for certain defense and national security obligations during a gap in funding, and for other purposes.
Client: TEVA PHARMACEUTICALS USA · Firm: RUBICON ADVISORS, LLC
Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2021 · fourth_quarter · Q4
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Rare disease issues Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2021 · third_quarter · Q3
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
AQUESTIVE THERAPEUTICS, INC via RUBICON ADVISORS, LLC
2021 · second_quarter · RR
H.R. 1629/S 250: Fairness in Orphan Drug Exclusivity Act
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Rare disease issues Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2021 · second_quarter · Q2
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Rare disease issues Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2021 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Rare disease issues Orphan drugs
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS)
HYPOPARATHYROIDISM ASSOCIATION via RUBICON ADVISORS, LLC
2020 · fourth_quarter · RR
Rare Disease Issues, Orphan drugs
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · fourth_quarter · Q4
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURE BLUE DIAGNOSTICS, A DIVISION OF PURE BLUE MEDICAL via RUBICON ADVISORS, LLC
2020 · third_quarter · 3T
Food and Drug Administration, COVID-19 Testing
Filing targets: Food & Drug Administration (FDA)
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · second_quarter · 2A
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · first_quarter · 1A
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2020 · third_quarter · Q3
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2020 · second_quarter · 2A
Food and Drug Administration, Orphan Drugs
Filing targets: Food & Drug Administration (FDA)
PURE BLUE DIAGNOSTICS, A DIVISION OF PURE BLUE MEDICAL via RUBICON ADVISORS, LLC
2020 · second_quarter · 2A
Food and Drug Administration, COVID-19 Testing
Filing targets: Food & Drug Administration (FDA)
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2020 · second_quarter · Q2
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2020 · second_quarter · Q2
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2020 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2020 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · second_quarter · Q2
Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURE BLUE DIAGNOSTICS, A DIVISION OF PURE BLUE MEDICAL via RUBICON ADVISORS, LLC
2020 · second_quarter · RR
Food and Drug Administration, COVID-19 Testing
ASCENDIS PHARMA, INC. via RUBICON ADVISORS, LLC
2020 · second_quarter · RR
Food and Drug Administration,Orphan Drugs
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2020 · first_quarter · 1A
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM AND COVID-19 FDA DRUG SHORTAGES
Filing targets: HOUSE OF REPRESENTATIVES
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2020 · first_quarter · Q1
Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2020 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2020 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2020 · first_quarter · Q1
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2019 · third_quarter · 3A
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM
Filing targets: HOUSE OF REPRESENTATIVES
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2019 · fourth_quarter · 4A
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM AND COVID-19 FDA DRUG SHORTAGES
Filing targets: HOUSE OF REPRESENTATIVES
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2019 · third_quarter · RA
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM AND COVID -19 FDA DRUG SHORTAGES
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2019 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2019 · fourth_quarter · Q4
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2019 · fourth_quarter · Q4
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2019 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2019 · third_quarter · Q3
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2019 · third_quarter · Q3
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVET PHARMACEUTICALS via RUBICON ADVISORS, LLC
2019 · third_quarter · RR
Generic Drug Pricing
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2019 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2019 · second_quarter · Q2
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2019 · second_quarter · Q2
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2019 · first_quarter · 1T
Medicare and Medicaid, Generic Prescription
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2019 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2019 · first_quarter · Q1
Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2019 · first_quarter · Q1
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2018 · fourth_quarter · Q4
Medicare and Medicaid, Generic Prescription
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2018 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2018 · fourth_quarter · Q4
Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2018 · fourth_quarter · Q4
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STATE MUTUAL INSURANCE COMPANY via RUBICON ADVISORS, LLC
2018 · first_quarter · 1T
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2018 · third_quarter · Q3
Medicare and Medicaid, Generic Prescription
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2018 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2018 · third_quarter · Q3
Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2018 · third_quarter · Q3
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALBANY MOLECULAR RESEARCH INC. via RUBICON ADVISORS, LLC
2018 · third_quarter · 3T
Border Adjustment tax
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2018 · second_quarter · Q2
Medicare and Medicaid, Generic Prescription
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Medicare and Medicaid, Generic Prescription
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LANNETT COMPANY, INC via RUBICON ADVISORS, LLC
2018 · first_quarter · RR
Generic Pharmaceuticals
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2018 · second_quarter · Q2
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2018 · second_quarter · Q2
Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2018 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALBANY MOLECULAR RESEARCH INC. via RUBICON ADVISORS, LLC
2018 · second_quarter · Q2
Border Adjustment tax
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
TEVA PHARMACEUTICALS USA via RUBICON ADVISORS, LLC
2018 · first_quarter · 1T
Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSCIOUS DISCIPLINE via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALBANY MOLECULAR RESEARCH INC. via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Border Adjustment tax
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DR. REDDY'S LABORATORIES, LTD via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
STATE MUTUAL INSURANCE COMPANY via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DYNAVAX TECHNOLOGIES via RUBICON ADVISORS, LLC
2018 · first_quarter · Q1
Prescription Drug User Fee
Filing targets: HOUSE OF REPRESENTATIVES, SENATE